CTI BioPharma Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Cash & Equivalents	85.02	68.43	29.04	15.11	13.71	6.87	Upgrade
Cash & Short-Term Investments	85.02	68.43	29.04	15.11	13.71	6.87	Upgrade
Cash Growth	66.92%	135.62%	92.23%	10.22%	99.41%	-9.89%	Upgrade
Accounts Receivable	322.78	322.27	226.83	213.81	193.25	114.69	Upgrade
Other Receivables	17.87	17.01	9.13	7.53	9.89	6.68	Upgrade
Receivables	396.62	385.56	260.04	239.35	229.34	138.41	Upgrade
Inventory	370.45	368.93	229.39	204.62	159.12	88.81	Upgrade
Other Current Assets	4.03	4.42	42.11	14.23	3.64	1.5	Upgrade
Total Current Assets	856.12	827.33	560.58	473.31	405.8	235.6	Upgrade
Property, Plant & Equipment	344.74	135.53	64.26	67.2	72.1	69.94	Upgrade
Long-Term Investments	117.18	115.49	-	-	-	-	Upgrade
Other Long-Term Assets	-	-	102.27	35	35	10	Upgrade
Total Assets	1,318	1,078	727.11	575.51	512.9	315.54	Upgrade
Accounts Payable	124.99	144.46	158.28	151.61	77.45	34.59	Upgrade
Accrued Expenses	6.24	7.14	7.49	5.49	5.47	3.32	Upgrade
Short-Term Debt	553.38	518.71	271.54	185.05	202.92	96.97	Upgrade
Current Portion of Long-Term Debt	8.72	9.75	8.03	6.45	5.87	4.12	Upgrade
Current Portion of Leases	2.94	3.08	-	-	-	0.64	Upgrade
Current Income Taxes Payable	32.3	29.63	10.9	12.56	9.68	4.29	Upgrade
Other Current Liabilities	13.64	12.63	5.74	3.82	4.84	4.32	Upgrade
Total Current Liabilities	742.21	725.39	461.98	364.99	306.22	148.26	Upgrade
Long-Term Debt	28.33	30	39.75	7.79	14.24	15.44	Upgrade
Long-Term Leases	5	5.56	-	-	-	-	Upgrade
Long-Term Deferred Tax Liabilities	59.45	11.5	8.19	7.93	7.59	6.61	Upgrade
Total Liabilities	834.99	772.45	509.92	380.7	328.05	170.31	Upgrade
Common Stock	76.38	76.38	76.38	77	77	77	Upgrade
Retained Earnings	240.3	228.86	140.81	120.12	107.85	71.16	Upgrade
Treasury Stock	-	-	-	-2.32	-	-2.93	Upgrade
Comprehensive Income & Other	166.35	0.66	-	-	-	-	Upgrade
Total Common Equity	483.04	305.9	217.19	194.8	184.85	145.23	Upgrade
Minority Interest	0	0	0	-	-	-	Upgrade
Shareholders' Equity	483.04	305.9	217.19	194.8	184.85	145.23	Upgrade
Total Liabilities & Equity	1,318	1,078	727.11	575.51	512.9	315.54	Upgrade
Total Debt	598.38	567.09	319.32	199.29	223.02	117.17	Upgrade
Net Cash (Debt)	-513.36	-498.66	-290.28	-184.18	-209.32	-110.29	Upgrade
Net Cash Per Share	-0.67	-0.65	-0.38	-0.24	-0.27	-0.15	Upgrade
Filing Date Shares Outstanding	763.81	763.81	763.81	763.81	770	750.85	Upgrade
Total Common Shares Outstanding	763.81	763.81	763.81	763.81	770	750.85	Upgrade
Working Capital	113.91	101.94	98.6	108.32	99.58	87.34	Upgrade
Book Value Per Share	0.63	0.40	0.28	0.26	0.24	0.19	Upgrade
Tangible Book Value	483.04	305.9	217.19	194.8	184.85	145.23	Upgrade
Tangible Book Value Per Share	0.63	0.40	0.28	0.26	0.24	0.19	Upgrade
Land	100.87	0.17	0.17	0.17	0.17	0.17	Upgrade
Buildings	115.79	11.35	10.88	10.42	10.27	10.27	Upgrade
Machinery	199.45	209.59	134.91	128.91	124.87	113.67	Upgrade
Construction In Progress	-	-	-	-	-	0.04	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.